ENFN Stock Summary and Trading Ideas (Enfusion Class A | NYSE:ENFN)

Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.

Enfusion Class A trades on the NYSE stock market under the symbol ENFN.

As of March 3, 2025, ENFN stock price climbed to $11.51 with 163,800 million shares trading.

ENFN has a beta of 0.27, meaning it tends to be less sensitive to market movements. ENFN has a correlation of 0.01 to the broad based SPY ETF.

ENFN has a market cap of $1.09 billion. This is considered a Small Cap stock.

Last quarter Enfusion Class A reported $51 million in Revenue and $.05 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.01.

In the last 3 years, ENFN traded as high as $17.13 and as low as $7.37.

The top ETF exchange traded funds that ENFN belongs to (by Net Assets): IWM, VGT, VXF, VTI, VB.

ENFN has outperformed the market in the last year with a price return of +31.8% while the SPY ETF gained +18.6%. ENFN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.9% and +4.6%, respectively, while the SPY returned -0.6% and -2.7%, respectively.

ENFN support price is $11.31 and resistance is $11.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENFN shares will trade within this expected range on the day.